Dupixent approved to treat bullous pemphigoid
Dupixent (dupilumab) has been approved by the FDA for the treatment of adult patients with bullous pemphigoid.| Drug Discovery and Development
By Brian Buntz | June 25, 2025| Drug Discovery and Development
By Dr. Qigan Cheng | August 18, 2025| Drug Discovery and Development
By Vinita Navadgi | October 3, 2025| Drug Discovery and Development
Dupixent (dupilumab) has been approved by the FDA for the treatment of adult patients with bullous pemphigoid.| Drug Discovery and Development
By Brian Buntz | April 30, 2025| Drug Discovery and Development
